These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28126271)

  • 21. Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target.
    Lepak A; Marchillo K; VanHecker J; Andes D
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7833-6. PubMed ID: 26392492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivalent alteration of quorum sensing in Staphylococcus aureus.
    Melamed Yerushalmi S; Buck ME; Lynn DM; Lemcoff NG; Meijler MM
    Chem Commun (Camb); 2013 Jun; 49(45):5177-9. PubMed ID: 23628938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes.
    Cameron DR; Howden BP; Peleg AY
    Clin Infect Dis; 2011 Sep; 53(6):576-82. PubMed ID: 21865195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic-resistant micrococcic infections.
    Finland M
    JAMA; 2014 Oct; 312(14):1475. PubMed ID: 25291597
    [No Abstract]   [Full Text] [Related]  

  • 25. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.
    Conlon BP
    Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
    Alder J
    Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of novel hamamelitannin analogues as potentiators for vancomycin in the treatment of biofilm related Staphylococcus aureus infections.
    Vermote A; Brackman G; Risseeuw MDP; Coenye T; Van Calenbergh S
    Bioorg Med Chem; 2016 Oct; 24(19):4563-4575. PubMed ID: 27507109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.
    Nishitani K; Beck CA; Rosenberg AF; Kates SL; Schwarz EM; Daiss JL
    Clin Orthop Relat Res; 2015 Sep; 473(9):2735-49. PubMed ID: 26013151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus: management principles and selection of antibiotic therapy.
    Elston DM
    Dermatol Clin; 2007 Apr; 25(2):157-64, vi. PubMed ID: 17430753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivo.
    Welling MM; Brouwer CP; van 't Hof W; Veerman EC; Amerongen AV
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3416-9. PubMed ID: 17620386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial disease trends and acquired antibiotic resistance: Part 2: Evolving microbial pathogens--antibiotic-resistant Staphylococcus aureus.
    Molinari JA
    Compend Contin Educ Dent; 1997 Apr; 18(4):320-2. PubMed ID: 9452540
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced delivery of gentamicin to infection foci due to Staphylococcus aureus using gold nanorods.
    Salouti M; Heidari Z; Ahangari A; Zare S
    Drug Deliv; 2016; 23(1):49-54. PubMed ID: 24758188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation of antibiotic resistance of Staphylococcus aureus in general practice.
    Manners BT; Grob PR; Beynon GP; Gibbs FJ
    Practitioner; 1976 Apr; 216(1294):439-42. PubMed ID: 1046672
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus.
    Ruef C
    Infection; 2004 Dec; 32(6):315-27. PubMed ID: 15597220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Rehm SJ; Tice A
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic sensitivity of S. aureus strains isolated from meningeal infections].
    Fedulov D; Mihalache DG
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):125-8. PubMed ID: 19326725
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: Design, synthesis, pharmacokinetics and antibacterial activities.
    Yang Z; Liu Y; Ahn J; Qiao Z; Endres JL; Gautam N; Huang Y; Li J; Zheng J; Alnouti Y; Bayles KW; Li R
    Eur J Med Chem; 2016 Nov; 124():129-137. PubMed ID: 27565555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.